These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28029076)

  • 1. EDITORIAL (Thematic Issue: Retinal Neurodegeneration in the Course of Diabetes: Neuroprotection as a Potential Treatment Target).
    Zorena K
    Curr Neuropharmacol; 2016; 14(8):782-783. PubMed ID: 28029076
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegeneration and Neuroinflammation in Diabetic Retinopathy: Potential Approaches to Delay Neuronal Loss.
    Kadłubowska J; Malaguarnera L; Wąż P; Zorena K
    Curr Neuropharmacol; 2016; 14(8):831-839. PubMed ID: 27306035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection for diabetic retinopathy.
    Imai H; Singh RSJ; Fort PE; Gardner TW
    Dev Ophthalmol; 2009; 44():56-68. PubMed ID: 19494653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fenofibrate on retinal neurodegeneration in an experimental model of type 2 diabetes.
    Bogdanov P; Hernández C; Corraliza L; Carvalho AR; Simó R
    Acta Diabetol; 2015 Feb; 52(1):113-22. PubMed ID: 25029994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy: neuron protection as a therapeutic target.
    Zhang X; Wang N; Barile GR; Bao S; Gillies M
    Int J Biochem Cell Biol; 2013 Jul; 45(7):1525-9. PubMed ID: 23506699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective.
    Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Curr Neuropharmacol; 2016; 14(8):805-809. PubMed ID: 26915422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegeneration in diabetic retinopathy: does it really matter?
    Simó R; Stitt AW; Gardner TW
    Diabetologia; 2018 Sep; 61(9):1902-1912. PubMed ID: 30030554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies.
    Zafar S; Sachdeva M; Frankfort BJ; Channa R
    Curr Diab Rep; 2019 Feb; 19(4):17. PubMed ID: 30806815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets.
    Chakravarthy H; Devanathan V
    J Mol Neurosci; 2018 Nov; 66(3):445-461. PubMed ID: 30293228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection by (endo)Cannabinoids in Glaucoma and Retinal Neurodegenerative Diseases.
    Rapino C; Tortolani D; Scipioni L; Maccarrone M
    Curr Neuropharmacol; 2018; 16(7):959-970. PubMed ID: 28738764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
    Simó R; Hernández C;
    Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in diabetic retinopathy.
    Hernández C; Simó R
    Curr Diab Rep; 2012 Aug; 12(4):329-37. PubMed ID: 22581259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection as a Therapeutic Target for Diabetic Retinopathy.
    Hernández C; Dal Monte M; Simó R; Casini G
    J Diabetes Res; 2016; 2016():9508541. PubMed ID: 27123463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
    Simó R; Hernández C;
    Trends Endocrinol Metab; 2014 Jan; 25(1):23-33. PubMed ID: 24183659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurodegeneration as a primary change and role of neuroprotection in diabetic retinopathy.
    Jindal V
    Mol Neurobiol; 2015; 51(3):878-84. PubMed ID: 24826918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Perspective in current neuroprotection strategies.
    Okada H; Matsuda Y; Chung J; Webster Crowley R; Lopes DK
    Neurosurg Focus; 2017 Apr; 42(4):E5. PubMed ID: 28366072
    [No Abstract]   [Full Text] [Related]  

  • 17. Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR.
    Grauslund J; Frydkjaer-Olsen U; Peto T; Fernández-Carneado J; Ponsati B; Hernández C; Cunha-Vaz J; Simó R;
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2257-2262. PubMed ID: 31112610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective role of melatonin on retinal ganglionar cell: In vitro an in vivo evidences.
    Del Valle Bessone C; Fajreldines HD; de Barboza GED; Tolosa de Talamoni NG; Allemandi DA; Carpentieri AR; Quinteros DA
    Life Sci; 2019 Feb; 218():233-240. PubMed ID: 30605647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin replacement: a new strategy for treating diabetic retinopathy.
    Hernández C; Simó R;
    Curr Med Chem; 2013; 20(26):3251-7. PubMed ID: 23745546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease.
    Miyazaki I; Asanuma M
    Curr Pharm Des; 2017; 23(33):4936-4947. PubMed ID: 28699520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.